Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.

MLA

van der Pouw Kraan, T. C., et al. “Responsiveness to Anti-Tumour Necrosis Factor Alpha Therapy Is Related to Pre-Treatment Tissue Inflammation Levels in Rheumatoid Arthritis Patients.” Annals of the Rheumatic Diseases, vol. 67, no. 4, Apr. 2008, pp. 563–66. EBSCOhost, https://doi.org/10.1136/ard.2007.081950.

APA

van der Pouw Kraan, T. C., Wijbrandts, C. A., van Baarsen, L. G., Rustenburg, F., Baggen, J. M., Verweij, C. L., & Tak, P. P. (2008). Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. Annals of the Rheumatic Diseases, 67(4), 563–566. https://doi.org/10.1136/ard.2007.081950

Chicago

van der Pouw Kraan, T C, C A Wijbrandts, L G van Baarsen, F Rustenburg, J M Baggen, C L Verweij, and P P Tak. 2008. “Responsiveness to Anti-Tumour Necrosis Factor Alpha Therapy Is Related to Pre-Treatment Tissue Inflammation Levels in Rheumatoid Arthritis Patients.” Annals of the Rheumatic Diseases 67 (4): 563–66. doi:10.1136/ard.2007.081950.